Grant: CELLERANT THERAPEUTICS, INC.
CELLERANT THERAPEUTICS, INC.
CDFA Program Title
Trans-NIH Recovery Act Research Support
Cellerant Therapeutic's goal is to develop an universal off-the shelf cellular therapeutic of megakaryocyte progenitors (MKP) for the mitigation of irradiation induced thrombocytopenia. These progenitors will be derived and expanded ex vivo from hematopoi